[HTML][HTML] New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review
P. aeruginosa is still one of the most threatening pathogens responsible for serious hospital-
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review.
AR Losito, F Raffaelli, P Del Giacomo… - Antibiotics (2079 …, 2022 - search.ebscohost.com
P. aeruginosa is still one of the most threatening pathogens responsible for serious hospital-
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review
AR Losito, F Raffaelli… - Antibiotics (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
P. aeruginosa is still one of the most threatening pathogens responsible for serious hospital-
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
New drugs for the treatment of Pseudomonas aeruginosa infections with limited treatment options: a narrative review.
AR Losito, F Raffaelli, P del Giacomo, M Tumbarello - 2022 - cabidigitallibrary.org
P. aeruginosa is still one of the most threatening pathogens responsible for serious
hospitalacquired infections. It is intrinsically resistant to many antimicrobial agents and …
hospitalacquired infections. It is intrinsically resistant to many antimicrobial agents and …
[HTML][HTML] New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review
AR Losito, F Raffaelli, P Del Giacomo, M Tumbarello - Antibiotics, 2022 - ncbi.nlm.nih.gov
P. aeruginosa is still one of the most threatening pathogens responsible for serious hospital-
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review.
AR Losito, F Raffaelli, P Del Giacomo… - Antibiotics (Basel …, 2022 - europepmc.org
P. aeruginosa is still one of the most threatening pathogens responsible for serious hospital-
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review
AR Losito, F Raffaelli, P Del Giacomo… - …, 2022 - search.proquest.com
P. aeruginosa is still one of the most threatening pathogens responsible for serious hospital-
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
acquired infections. It is intrinsically resistant to many antimicrobial agents and additional …
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review
AR Losito, F Raffaelli, PD Giacomo… - Antibiotics (Web), 2022 - jglobal.jst.go.jp
Magiorakos, AP; Srinivasan, A.; Carey, RB; Carmeli, Y.; Falagas, ME; Giske, CG; Harbarth,
S.; Hindler, JF; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-resistant, extensively …
S.; Hindler, JF; Kahlmeter, G.; Olsson-Liljequist, B.; et al. Multidrug-resistant, extensively …